GnRH Hormone for IVF Embryo Support
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study tests whether a hormone called GnRH can improve success rates during IVF (in vitro fertilization) by supporting the embryo after transfer. If you're having IVF for the first to third time and your doctor is considering different support methods, this trial may explore options for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 45 years old
- You are undergoing IVF for ovulation problems, blocked tubes, low egg reserve, or male partner infertility
- This is your first, second, or third IVF cycle
- Your BMI is between 19 and 35 (neither too low nor too high)
- You are planning a fresh embryo transfer (not frozen), and your embryos have not had genetic testing (PGT)
- You do not have a history of multiple failed embryo transfers, moderate-to-severe endometriosis, or blocked fallopian tubes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medication called a GnRH agonist during the luteal phase (the time after egg retrieval) can help with IVF success. It is for people who are using a specific medication protocol (recombinant FSH with an antagonist) and have certain hormone levels.
This trial tests whether a hormone called GnRH can help support the lining of the uterus after IVF, ICSI, or frozen embryo (FET) embryo transfer. It may be offered around the time of embryo transfer to improve the chances of a successful implantation.
This trial tests whether giving a medication called a GnRH agonist (which affects hormones) before a frozen embryo transfer can improve the chances of pregnancy in women with infertility. It aims to see if this treatment helps the uterus accept the embryo better.
This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.
This trial tests whether giving extra luteinizing hormone (LH) can improve embryo quality in women with very low LH levels during IVF. It may help you if you have low LH and are using a specific type of fertility medication.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
Hear when a new Fresh Embryo Transfer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.